The long-term trend of the EPS is a vital number as it helps understand the future potential of SenesTech. It is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -10.00 % over the last twelve months. The long-term trend in EPS shows how well the management of SenesTech is adding value for shareholders.

SenesTech is in the basic materials sector and is part of the agriculture industry. The company CEO is Loretta P. Mayer. SenesTech Inc is a biotech platform and research company. The Company is engaged in developing technology for managing animal pest populations through fertility control.

Previous Intraday Performance:

The SNES shares had a previous change of -0.20% which opened at 0.79 and closed at 0.76. It moved to an intraday high of 0.79 and a low of 0.76.

PR Newswire:  SenesTech Announces Largest Shipment of ContraPest Ever to Washington D.C.

Historical Performance:

Over the last five trading days, SNES shares returned 16.33% and in the past 30 trading days it returned 14.94%. Over three months, it changed 6.29%. In one year it has changed 4.18% and within that year its 52-week high was 2.37 and its 52-week low was 0.30. SNES stock is 153.33% above its 52 Week Low.

Our calculations result in a 200 day moving average of 0.90 and a 50 day moving average of 0.70. Right now, SNES stock is trading -15.94% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.

PR Newswire:  SenesTech Announces Largest Shipment of ContraPest Ever to Washington D.C.


The company has a market cap of $17.8m with 23.5m shares outstanding and a float of 22.1m shares. Trading volume was 71,915 shares and has experienced an average volume of 134,729 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.


The last annual reported EPS for SenesTech was -1.12 which ended on 31st of December 2017. Based on 1 analyst estimate, the estimated EPS for the next quarter is -0.11.

Below was the last reported quarterly earnings per share:
09-30-2018:  -0.14
06-30-2018:  -0.25
03-31-2018:  -0.16
12-31-2017:  -0.15

Base on our calculations, the intrinsic value per share is 10.42, which means it might be undervalued and has a margin of safety of 92.71%

Indicators Also to Watch:

Based on the latest filings, there is 7.30% of insider ownership and 18.50% of institutional ownership. Short-interest was 0, which was 0.00% of shares outstanding. The short-interest ratio or days-to-cover ratio was 0.00.

I calculated the beta to be 0.72

SeekingAlpha:  XEC and PCG among premarket losers

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is -193.74%, return on assets is -151.63%, price-to-sales is 111.62 and price-to-book is 2.07.

Company Score Card:

Results are out of six:
 2  : Growth Expectations Result
 5  : Financial Safety Result
 0  : Past Performance Result
 3  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).


Please enter your comment!
Please enter your name here